y 27632 has been researched along with Cholestasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dold, S; Jeppsson, B; Laschke, MW; Menger, MD; Schilling, MK; Thorlacius, H | 1 |
| Dold, S; Jeppsson, B; Laschke, MW; Menger, MD; Thorlacius, H | 1 |
2 other study(ies) available for y 27632 and Cholestasis
| Article | Year |
|---|---|
Rho-kinase inhibitor attenuates cholestasis-induced CXC chemokine formation, leukocyte recruitment, and hepatocellular damage in the liver.
Topics: Alanine Transaminase; Amides; Animals; Antihypertensive Agents; Aspartate Aminotransferases; Chemokines, CXC; Cholestasis; Cholestasis, Intrahepatic; Enzyme-Linked Immunosorbent Assay; Liver; Male; Mice; Mice, Inbred C57BL; Pyridines; rho-Associated Kinases | 2010 |
The Rho-kinase inhibitor Y-27632 inhibits cholestasis-induced platelet interactions in the hepatic microcirculation.
Topics: Amides; Animals; Blood Platelets; Cholestasis; Liver; Liver Circulation; Male; Mice; Mice, Inbred C57BL; Microcirculation; Pyridines; rho-Associated Kinases | 2009 |